Upside is a financial technology entity that allows its users to earn cashbacks on current purchases so that they can save on their next purchase. The app uses an open-banking-marketing-platform that enables customers to automatically start saving by harvesting upside from their everyday spending and allows retailers to sell more inventory. Upside claims that 11.5 million people in the UK have less than £100 in savings. It aims to solve this problem and become a contender in the cashback segment. Since its incorporation in January 2020, Upside has raised £540,000+ from founders and SEIS Angel Investors. It has also signed-up 700+ consumers as private alpha testers to smoothen the app. The company will use the investment to onboard more retail partners, build out a self-serve retailer platform, build out Upside-as-a-Service Application Programming Interface (API) gateway, and prepare for Seed funding in Q1 of 2021.
days to go:
Expired
investment:
£351,047
EverUp is the UK's first digitally-native prize-linked money account. The company's objective is to shift consumers from the conventional savings account to an application that rewards users with virtual coins for the money they save. Users can then use the virtual coins to play EverUp's online games or lottery events and win tax-free, cash prizes, or more virtual coins to play. The company envisions to build a full-scale financial hub where its customers can accomplish all types of financial transactions. EverUp will reward users for solidifying good financial behaviours through a prize-linked suite of products. EverUp has been accepted by the Financial Conduct Authority (FCA) Innovation Hub to act as a registered Electronic Money Institution (EMI). EverUp is soon going to launch its application across iOS and Android. The company will use the investment to fund its initial operations and earn market traction.
days to go:
Expired
investment:
£478,889
OnCare is a digital care management software that is digitising elderly care, creating a global care marketplace via the OpenTable model to care. OnCare provides care agencies with the power to plan, manage and enhance care delivery and staff communication. Their mission is to make care easier for everyone. OnCare is currently live with over 110 home-care agencies around the UK, and more than 1100 care workers. The company is planning to enter markets of Hong Kong, Canada and Israel. With the proceeds, the company will use this fund for people, office space, technology, software, hosting and marketing.
days to go:
Expired
investment:
£96,040
Themis is a regulatory technology company that helps organisations mitigate the risk and impact of all forms of financial crime such as money laundering, bribery, corruption, cybercrime, theft, slavery/human trafficking, and fraud. The platform is designed to provide insights and intelligence on the latest threats, trends, and criminal techniques whilst helping clients complete due diligence on their clients, staff, and supply chains. Themis works alongside the Themis Charitable Trust to ensure the reduction of financial crime. The company also supports the UN Global Compact taking into account the fundamental responsibilities of business in the areas of human rights, labour, environment, and anti-corruption. Themis will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,300,000
Please watch the video for more information
days to go:
Expired
investment:
£215,000
FounderTribes helps budding entrepreneurs get access to advice, connections, and capital from established founders via its educational app. It argues that around 581 million people will never gain access to Venture Capital (VC) funding or avail meaningful entrepreneurial education. FounderTribes intends to change that and become a contender in the Education Technology (EdTech) market worth $5 trillion. Users can use the app to get personalised feedback from FounderTribes's community of seasoned entrepreneurs and investors, get actionable tips from industry-specific networks to work on problem areas, and avail alternative financing to start and scale their business. FounderTribes has raised £700,000+ as part of this round, onboarded over 400 investors and 500 mentors on its portal, and signed its first paying customer, Capital Enterprise, with £20,000 worth of subscriptions. It will use 76% of the investment for HR costs, 10% towards video content creation, 3% towards IT expenses, 2% towards marketing expenses, and 8% for general operations.
days to go:
Expired
investment:
£805,960
Giftgaming is a non-intrusive game advertising platform. The advertisments can be closed quickly and the player is rewarded with currency or power ups for their game after viewing the advert.
days to go:
Expired
investment:
£94,743
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.
days to go:
Expired
investment:
£215,946
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
Measuring customer interactions within a retail environment to gain behaviour insight and knowledge. Shoppar's technology is installed in-store and analyses various aspects of a customer such as their gender, age and attention span. This information can be utilised to develop marketing campaigns to target audiences. Clients of Shoppar include Samsung, Sky, Hugo Boss and Heineken, with many more currently in advanced discussions. All data collected is GDPR compliant and there is no identifying information of an individual stored.
days to go:
Expired
investment:
£240,008
